

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 9.78285127 |
| 2 | drug catabolic process (GO:0042737) | 9.33941589 |
| 3 | complement activation, alternative pathway (GO:0006957) | 8.67023770 |
| 4 | glyoxylate metabolic process (GO:0046487) | 8.35667882 |
| 5 | * epoxygenase P450 pathway (GO:0019373) | 8.35609771 |
| 6 | regulation of fibrinolysis (GO:0051917) | 8.18966143 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 8.15441784 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 8.15441784 |
| 9 | * omega-hydroxylase P450 pathway (GO:0097267) | 8.14016923 |
| 10 | regulation of protein activation cascade (GO:2000257) | 7.73298849 |
| 11 | negative regulation of fibrinolysis (GO:0051918) | 7.50475350 |
| 12 | ethanol oxidation (GO:0006069) | 7.44448259 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 7.38335847 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.38335847 |
| 15 | regulation of complement activation (GO:0030449) | 7.38239613 |
| 16 | urea metabolic process (GO:0019627) | 6.57603838 |
| 17 | drug metabolic process (GO:0017144) | 6.56890544 |
| 18 | protein carboxylation (GO:0018214) | 6.53028662 |
| 19 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.53028662 |
| 20 | fibrinolysis (GO:0042730) | 6.34211505 |
| 21 | oxidative demethylation (GO:0070989) | 6.19648486 |
| 22 | aromatic amino acid family catabolic process (GO:0009074) | 6.16665779 |
| 23 | negative regulation of cholesterol transport (GO:0032375) | 6.11030295 |
| 24 | negative regulation of sterol transport (GO:0032372) | 6.11030295 |
| 25 | serine family amino acid catabolic process (GO:0009071) | 6.07424175 |
| 26 | ethanol metabolic process (GO:0006067) | 5.98130051 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 5.97483989 |
| 28 | blood coagulation, intrinsic pathway (GO:0007597) | 5.96078290 |
| 29 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.90703935 |
| 30 | imidazole-containing compound metabolic process (GO:0052803) | 5.85657048 |
| 31 | bile acid biosynthetic process (GO:0006699) | 5.68974179 |
| 32 | urea cycle (GO:0000050) | 5.65600903 |
| 33 | regulation of triglyceride catabolic process (GO:0010896) | 5.56152205 |
| 34 | cellular glucuronidation (GO:0052695) | 5.49748297 |
| 35 | regulation of plasminogen activation (GO:0010755) | 5.49158584 |
| 36 | protein activation cascade (GO:0072376) | 5.31969687 |
| 37 | phenylpropanoid metabolic process (GO:0009698) | 5.31175610 |
| 38 | glucuronate metabolic process (GO:0019585) | 5.23247063 |
| 39 | uronic acid metabolic process (GO:0006063) | 5.23247063 |
| 40 | glycine metabolic process (GO:0006544) | 5.20755195 |
| 41 | complement activation (GO:0006956) | 5.09614735 |
| 42 | S-adenosylmethionine metabolic process (GO:0046500) | 5.02836673 |
| 43 | bile acid metabolic process (GO:0008206) | 5.02108322 |
| 44 | complement activation, classical pathway (GO:0006958) | 5.01278589 |
| 45 | opsonization (GO:0008228) | 5.00259282 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.95236786 |
| 47 | negative regulation of hemostasis (GO:1900047) | 4.73854970 |
| 48 | negative regulation of blood coagulation (GO:0030195) | 4.73854970 |
| 49 | regulation of humoral immune response (GO:0002920) | 4.69073955 |
| 50 | glutamate metabolic process (GO:0006536) | 4.57856737 |
| 51 | bile acid and bile salt transport (GO:0015721) | 4.57659561 |
| 52 | acute-phase response (GO:0006953) | 4.52752576 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.51206047 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.51206047 |
| 55 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.47891745 |
| 56 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.47891745 |
| 57 | negative regulation of protein activation cascade (GO:2000258) | 4.45950649 |
| 58 | phospholipid efflux (GO:0033700) | 4.41163924 |
| 59 | indole-containing compound catabolic process (GO:0042436) | 4.39975996 |
| 60 | indolalkylamine catabolic process (GO:0046218) | 4.39975996 |
| 61 | tryptophan catabolic process (GO:0006569) | 4.39975996 |
| 62 | cytolysis (GO:0019835) | 4.37922217 |
| 63 | alkaloid metabolic process (GO:0009820) | 4.37030040 |
| 64 | plasma lipoprotein particle remodeling (GO:0034369) | 4.34697138 |
| 65 | protein-lipid complex remodeling (GO:0034368) | 4.34697138 |
| 66 | macromolecular complex remodeling (GO:0034367) | 4.34697138 |
| 67 | alpha-amino acid catabolic process (GO:1901606) | 4.30554438 |
| 68 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.29995793 |
| 69 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.29995793 |
| 70 | negative regulation of coagulation (GO:0050819) | 4.29820762 |
| 71 | response to mercury ion (GO:0046689) | 4.24965541 |
| 72 | negative regulation of wound healing (GO:0061045) | 4.23759366 |
| 73 | cellular ketone body metabolic process (GO:0046950) | 4.22185450 |
| 74 | amino-acid betaine metabolic process (GO:0006577) | 4.21392600 |
| 75 | cholesterol efflux (GO:0033344) | 4.19455681 |
| 76 | high-density lipoprotein particle remodeling (GO:0034375) | 4.17748437 |
| 77 | serine family amino acid metabolic process (GO:0009069) | 4.15044557 |
| 78 | positive regulation of blood coagulation (GO:0030194) | 4.11115714 |
| 79 | positive regulation of hemostasis (GO:1900048) | 4.11115714 |
| 80 | aromatic amino acid family metabolic process (GO:0009072) | 4.06951015 |
| 81 | arginine metabolic process (GO:0006525) | 4.01448626 |
| 82 | flavonoid metabolic process (GO:0009812) | 3.92074246 |
| 83 | reverse cholesterol transport (GO:0043691) | 3.88703648 |
| 84 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.81888757 |
| 85 | negative regulation of lipase activity (GO:0060192) | 3.80680877 |
| 86 | positive regulation of coagulation (GO:0050820) | 3.77367723 |
| 87 | tryptophan metabolic process (GO:0006568) | 3.74131385 |
| 88 | regulation of cholesterol esterification (GO:0010872) | 3.73176848 |
| 89 | intestinal cholesterol absorption (GO:0030299) | 3.72365145 |
| 90 | negative regulation of complement activation (GO:0045916) | 3.70493529 |
| 91 | ketone body metabolic process (GO:1902224) | 3.70464908 |
| 92 | cellular amino acid catabolic process (GO:0009063) | 3.68260618 |
| 93 | serine family amino acid biosynthetic process (GO:0009070) | 3.65210735 |
| 94 | sodium-independent organic anion transport (GO:0043252) | 3.59868367 |
| 95 | cysteine metabolic process (GO:0006534) | 3.51792960 |
| 96 | positive regulation of lipid catabolic process (GO:0050996) | 3.46673086 |
| 97 | hormone catabolic process (GO:0042447) | 3.45626727 |
| 98 | * xenobiotic metabolic process (GO:0006805) | 3.45371636 |
| 99 | acute inflammatory response (GO:0002526) | 3.44640234 |
| 100 | heme transport (GO:0015886) | 3.41052372 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.91286805 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.83596823 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.64887364 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.63428732 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.40585200 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.51436906 |
| 7 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.41367588 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.89503826 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.74775979 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.46436485 |
| 11 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.11055058 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06475238 |
| 13 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.00071000 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.9878781 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.96196763 |
| 16 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.83863454 |
| 17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.82928953 |
| 18 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.44731322 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.30611840 |
| 20 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.22512593 |
| 21 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.19236505 |
| 22 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.16095222 |
| 23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14003449 |
| 24 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11810073 |
| 25 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.10954027 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09069274 |
| 27 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.01696669 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.01575602 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.98507866 |
| 30 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.93472793 |
| 31 | CBP_21632823_ChIP-Seq_H3396_Human | 0.89852699 |
| 32 | AR_20517297_ChIP-Seq_VCAP_Human | 0.89565460 |
| 33 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.88909964 |
| 34 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.87972220 |
| 35 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.87526679 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.85001404 |
| 37 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.84670932 |
| 38 | GATA1_22025678_ChIP-Seq_K562_Human | 0.83834874 |
| 39 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.81674298 |
| 40 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.81540017 |
| 41 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.80514617 |
| 42 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.79760051 |
| 43 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.79026751 |
| 44 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.78817621 |
| 45 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78683800 |
| 46 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.78623215 |
| 47 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.78501405 |
| 48 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.75984999 |
| 49 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.73947261 |
| 50 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.73184470 |
| 51 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.73161846 |
| 52 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.72907805 |
| 53 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.71526919 |
| 54 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71121365 |
| 55 | * NFYA_21822215_ChIP-Seq_K562_Human | 0.70801051 |
| 56 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.70252610 |
| 57 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.69489511 |
| 58 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.69173661 |
| 59 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.68958166 |
| 60 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.68707315 |
| 61 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.67485094 |
| 62 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.66588826 |
| 63 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.66577931 |
| 64 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.65606907 |
| 65 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.63512195 |
| 66 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.62444322 |
| 67 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.61802732 |
| 68 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.61685360 |
| 69 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.61153960 |
| 70 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61067263 |
| 71 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.60797808 |
| 72 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.60721699 |
| 73 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.60647860 |
| 74 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.60502674 |
| 75 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.60493580 |
| 76 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.60193973 |
| 77 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.59901006 |
| 78 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.59434683 |
| 79 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.59251530 |
| 80 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.58393057 |
| 81 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 0.58055913 |
| 82 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.57657156 |
| 83 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.57472769 |
| 84 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.57012672 |
| 85 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.54877478 |
| 86 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.54741455 |
| 87 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.54364665 |
| 88 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.54161873 |
| 89 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.54161873 |
| 90 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.53854990 |
| 91 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.53671147 |
| 92 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.53671147 |
| 93 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.53258751 |
| 94 | NCOR_22424771_ChIP-Seq_293T_Human | 0.52900650 |
| 95 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.52810326 |
| 96 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.52320061 |
| 97 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.52313785 |
| 98 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.52285506 |
| 99 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.51841111 |
| 100 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.51426136 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.32585763 |
| 2 | MP0005360_urolithiasis | 6.60394939 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.21342499 |
| 4 | MP0003195_calcinosis | 6.10364164 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.88207729 |
| 6 | MP0005365_abnormal_bile_salt | 5.40224502 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 4.46845552 |
| 8 | MP0003252_abnormal_bile_duct | 4.07607122 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.02302277 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.87902465 |
| 11 | MP0003868_abnormal_feces_composition | 2.72493105 |
| 12 | MP0005332_abnormal_amino_acid | 2.63086734 |
| 13 | MP0009697_abnormal_copulation | 2.53430385 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.26765542 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.23515096 |
| 16 | MP0010368_abnormal_lymphatic_system | 2.02299832 |
| 17 | MP0002876_abnormal_thyroid_physiology | 1.82754334 |
| 18 | MP0009840_abnormal_foam_cell | 1.81638140 |
| 19 | MP0000609_abnormal_liver_physiology | 1.78823225 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.67424301 |
| 21 | MP0001764_abnormal_homeostasis | 1.59965463 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 1.47584573 |
| 23 | MP0005670_abnormal_white_adipose | 1.47492447 |
| 24 | MP0009053_abnormal_anal_canal | 1.24349349 |
| 25 | MP0009643_abnormal_urine_homeostasis | 1.21331664 |
| 26 | MP0001661_extended_life_span | 1.15697462 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.14269780 |
| 28 | MP0002132_abnormal_respiratory_system | 1.11385330 |
| 29 | MP0003656_abnormal_erythrocyte_physiolo | 1.11365104 |
| 30 | MP0009764_decreased_sensitivity_to | 1.09323428 |
| 31 | MP0005408_hypopigmentation | 1.00868669 |
| 32 | MP0000598_abnormal_liver_morphology | 1.00825763 |
| 33 | MP0008872_abnormal_physiological_respon | 0.98997806 |
| 34 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.98519197 |
| 35 | MP0002971_abnormal_brown_adipose | 0.93417104 |
| 36 | MP0002168_other_aberrant_phenotype | 0.91420937 |
| 37 | MP0005636_abnormal_mineral_homeostasis | 0.90357681 |
| 38 | MP0002282_abnormal_trachea_morphology | 0.88880861 |
| 39 | MP0004043_abnormal_pH_regulation | 0.87828576 |
| 40 | MP0009642_abnormal_blood_homeostasis | 0.83392011 |
| 41 | MP0005395_other_phenotype | 0.83117702 |
| 42 | MP0009763_increased_sensitivity_to | 0.82938213 |
| 43 | MP0003879_abnormal_hair_cell | 0.81283835 |
| 44 | MP0005376_homeostasis/metabolism_phenot | 0.80536281 |
| 45 | MP0005451_abnormal_body_composition | 0.79840412 |
| 46 | MP0003186_abnormal_redox_activity | 0.79494431 |
| 47 | MP0008469_abnormal_protein_level | 0.74692813 |
| 48 | MP0000604_amyloidosis | 0.74159540 |
| 49 | MP0002249_abnormal_larynx_morphology | 0.73481036 |
| 50 | MP0005535_abnormal_body_temperature | 0.72846354 |
| 51 | MP0003690_abnormal_glial_cell | 0.66023716 |
| 52 | MP0003011_delayed_dark_adaptation | 0.63995234 |
| 53 | MP0005266_abnormal_metabolism | 0.62682782 |
| 54 | MP0005187_abnormal_penis_morphology | 0.61571364 |
| 55 | MP0001756_abnormal_urination | 0.61516736 |
| 56 | MP0001915_intracranial_hemorrhage | 0.61336128 |
| 57 | MP0002078_abnormal_glucose_homeostasis | 0.61300261 |
| 58 | MP0005334_abnormal_fat_pad | 0.60772174 |
| 59 | MP0004130_abnormal_muscle_cell | 0.59993982 |
| 60 | MP0008874_decreased_physiological_sensi | 0.58775280 |
| 61 | MP0002136_abnormal_kidney_physiology | 0.50783488 |
| 62 | MP0005083_abnormal_biliary_tract | 0.49954108 |
| 63 | MP0004782_abnormal_surfactant_physiolog | 0.49612850 |
| 64 | MP0003638_abnormal_response/metabolism_ | 0.47269709 |
| 65 | MP0005464_abnormal_platelet_physiology | 0.47020457 |
| 66 | MP0009785_altered_susceptibility_to | 0.45655078 |
| 67 | MP0005166_decreased_susceptibility_to | 0.45324790 |
| 68 | MP0009765_abnormal_xenobiotic_induced | 0.45242793 |
| 69 | MP0002928_abnormal_bile_duct | 0.43258624 |
| 70 | MP0005448_abnormal_energy_balance | 0.40852337 |
| 71 | MP0006036_abnormal_mitochondrial_physio | 0.40458924 |
| 72 | MP0000249_abnormal_blood_vessel | 0.38939857 |
| 73 | MP0003075_altered_response_to | 0.38350950 |
| 74 | MP0000467_abnormal_esophagus_morphology | 0.37790898 |
| 75 | MP0004883_abnormal_blood_vessel | 0.37704563 |
| 76 | MP0005023_abnormal_wound_healing | 0.36615609 |
| 77 | MP0002332_abnormal_exercise_endurance | 0.36570499 |
| 78 | MP0000566_synostosis | 0.35925604 |
| 79 | MP0005220_abnormal_exocrine_pancreas | 0.34476303 |
| 80 | MP0003953_abnormal_hormone_level | 0.32249379 |
| 81 | MP0001986_abnormal_taste_sensitivity | 0.32175949 |
| 82 | MP0001545_abnormal_hematopoietic_system | 0.32110043 |
| 83 | MP0005397_hematopoietic_system_phenotyp | 0.32110043 |
| 84 | MP0005164_abnormal_response_to | 0.30376425 |
| 85 | MP0005084_abnormal_gallbladder_morpholo | 0.28665699 |
| 86 | MP0000639_abnormal_adrenal_gland | 0.26279833 |
| 87 | MP0009115_abnormal_fat_cell | 0.25245050 |
| 88 | MP0005647_abnormal_sex_gland | 0.24920717 |
| 89 | MP0005058_abnormal_lysosome_morphology | 0.21754417 |
| 90 | MP0005646_abnormal_pituitary_gland | 0.21595732 |
| 91 | MP0003718_maternal_effect | 0.21404672 |
| 92 | MP0006292_abnormal_olfactory_placode | 0.20160862 |
| 93 | MP0001851_eye_inflammation | 0.19587161 |
| 94 | MP0001944_abnormal_pancreas_morphology | 0.19432928 |
| 95 | MP0002135_abnormal_kidney_morphology | 0.18338460 |
| 96 | MP0003705_abnormal_hypodermis_morpholog | 0.18333320 |
| 97 | MP0001845_abnormal_inflammatory_respons | 0.18290031 |
| 98 | MP0005666_abnormal_adipose_tissue | 0.17784949 |
| 99 | MP0002970_abnormal_white_adipose | 0.17326153 |
| 100 | MP0005377_hearing/vestibular/ear_phenot | 0.17289896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 9.40749062 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 9.11632207 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 8.48075232 |
| 4 | Abnormality of complement system (HP:0005339) | 8.07865339 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 7.03749358 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 6.51730741 |
| 7 | Joint hemorrhage (HP:0005261) | 6.50342784 |
| 8 | Conjugated hyperbilirubinemia (HP:0002908) | 6.47972360 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.84032054 |
| 10 | Xanthomatosis (HP:0000991) | 5.21449136 |
| 11 | Glomerulonephritis (HP:0000099) | 5.06874109 |
| 12 | Abnormality of pyrimidine metabolism (HP:0004353) | 5.04456470 |
| 13 | Intrahepatic cholestasis (HP:0001406) | 4.92494979 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.82379240 |
| 15 | Spontaneous abortion (HP:0005268) | 4.25848455 |
| 16 | Abnormality of the intrinsic pathway (HP:0010989) | 4.25356291 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.16603811 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 4.09240938 |
| 19 | Nephritis (HP:0000123) | 3.85778338 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.76384713 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.70198547 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 3.63062312 |
| 23 | Hyperglycinemia (HP:0002154) | 3.46231343 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 3.39515675 |
| 25 | Generalized aminoaciduria (HP:0002909) | 3.26989853 |
| 26 | Delayed CNS myelination (HP:0002188) | 3.20854615 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.11848216 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.11848216 |
| 29 | Hyperammonemia (HP:0001987) | 3.05652637 |
| 30 | Fair hair (HP:0002286) | 2.95716981 |
| 31 | Abnormality of nucleobase metabolism (HP:0010932) | 2.94852641 |
| 32 | Neonatal hypoglycemia (HP:0001998) | 2.94762823 |
| 33 | Fat malabsorption (HP:0002630) | 2.92119374 |
| 34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.88700734 |
| 35 | Hypercholesterolemia (HP:0003124) | 2.86923969 |
| 36 | Gingival bleeding (HP:0000225) | 2.80133580 |
| 37 | Epidermoid cyst (HP:0200040) | 2.79630863 |
| 38 | Mitral stenosis (HP:0001718) | 2.78631995 |
| 39 | Vascular calcification (HP:0004934) | 2.76019996 |
| 40 | Rickets (HP:0002748) | 2.67188252 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 2.66215476 |
| 42 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.63801542 |
| 43 | Hyperglycinuria (HP:0003108) | 2.63263509 |
| 44 | Hemorrhage of the eye (HP:0011885) | 2.63142730 |
| 45 | Thrombophlebitis (HP:0004418) | 2.62327183 |
| 46 | Osteomalacia (HP:0002749) | 2.52082649 |
| 47 | Hyperbilirubinemia (HP:0002904) | 2.50241449 |
| 48 | Alkalosis (HP:0001948) | 2.44978909 |
| 49 | Cardiovascular calcification (HP:0011915) | 2.43241927 |
| 50 | Purpura (HP:0000979) | 2.42593819 |
| 51 | Hepatocellular carcinoma (HP:0001402) | 2.33253187 |
| 52 | Pulmonary embolism (HP:0002204) | 2.32696121 |
| 53 | Menorrhagia (HP:0000132) | 2.29241337 |
| 54 | Steatorrhea (HP:0002570) | 2.27946358 |
| 55 | Ketosis (HP:0001946) | 2.20301348 |
| 56 | Hyperphosphaturia (HP:0003109) | 2.20106794 |
| 57 | Gout (HP:0001997) | 2.19283378 |
| 58 | Metabolic acidosis (HP:0001942) | 2.18933662 |
| 59 | Generalized hypopigmentation of hair (HP:0011358) | 2.06701554 |
| 60 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 10.0969094 |
| 61 | Complement deficiency (HP:0004431) | 10.0704844 |
| 62 | Abnormality of purine metabolism (HP:0004352) | 1.98784220 |
| 63 | Cholelithiasis (HP:0001081) | 1.97611241 |
| 64 | Abnormality of urine glucose concentration (HP:0011016) | 1.96885966 |
| 65 | Glycosuria (HP:0003076) | 1.96885966 |
| 66 | Reduced antithrombin III activity (HP:0001976) | 1.94083375 |
| 67 | Elevated alkaline phosphatase (HP:0003155) | 1.93598937 |
| 68 | Irritability (HP:0000737) | 1.93342953 |
| 69 | Arthropathy (HP:0003040) | 1.89151166 |
| 70 | Abnormality of vitamin metabolism (HP:0100508) | 1.88345025 |
| 71 | Myocardial infarction (HP:0001658) | 1.86709387 |
| 72 | Abnormal gallbladder morphology (HP:0012437) | 1.86013913 |
| 73 | Blue irides (HP:0000635) | 1.84138172 |
| 74 | Hypophosphatemic rickets (HP:0004912) | 1.82754496 |
| 75 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81840455 |
| 76 | Gangrene (HP:0100758) | 1.78661407 |
| 77 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.77358881 |
| 78 | Joint swelling (HP:0001386) | 1.77355831 |
| 79 | Impaired platelet aggregation (HP:0003540) | 1.76896657 |
| 80 | Abnormal platelet function (HP:0011869) | 1.76896657 |
| 81 | Cholecystitis (HP:0001082) | 1.75971993 |
| 82 | Abnormal gallbladder physiology (HP:0012438) | 1.75971993 |
| 83 | Abnormal urine phosphate concentration (HP:0012599) | 1.75355650 |
| 84 | Increased mean platelet volume (HP:0011877) | 1.74034454 |
| 85 | Enlarged kidneys (HP:0000105) | 1.73271058 |
| 86 | Abnormality of the Achilles tendon (HP:0005109) | 1.72359349 |
| 87 | Abnormality of proline metabolism (HP:0010907) | 1.71963975 |
| 88 | Hydroxyprolinuria (HP:0003080) | 1.71963975 |
| 89 | Abnormality of iron homeostasis (HP:0011031) | 1.71596771 |
| 90 | Cerebral palsy (HP:0100021) | 1.69212597 |
| 91 | Proximal tubulopathy (HP:0000114) | 1.64790478 |
| 92 | Increased serum ferritin (HP:0003281) | 1.64762429 |
| 93 | Bifid scrotum (HP:0000048) | 1.64046676 |
| 94 | Epistaxis (HP:0000421) | 1.64038193 |
| 95 | Poikilocytosis (HP:0004447) | 1.62922536 |
| 96 | Hypochromic microcytic anemia (HP:0004840) | 1.61836942 |
| 97 | Atrioventricular block (HP:0001678) | 1.61613677 |
| 98 | Skin nodule (HP:0200036) | 1.61200260 |
| 99 | Lethargy (HP:0001254) | 1.58404595 |
| 100 | Neonatal onset (HP:0003623) | 1.57794268 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK3 | 6.72735968 |
| 2 | ERN1 | 5.26900242 |
| 3 | OXSR1 | 3.29822687 |
| 4 | FGFR4 | 2.96139730 |
| 5 | BCKDK | 2.74143380 |
| 6 | PIK3CG | 2.63882859 |
| 7 | FRK | 2.60968926 |
| 8 | SIK1 | 2.39139924 |
| 9 | PIK3CA | 2.19997418 |
| 10 | TRIB3 | 2.19357516 |
| 11 | PRKACG | 2.15061204 |
| 12 | RIPK1 | 1.91229154 |
| 13 | NTRK3 | 1.90366083 |
| 14 | TYK2 | 1.88415114 |
| 15 | PRKAA2 | 1.85458049 |
| 16 | SGK2 | 1.68424145 |
| 17 | TIE1 | 1.67109292 |
| 18 | PRKCG | 1.66181254 |
| 19 | MAPK11 | 1.65251138 |
| 20 | EPHA3 | 1.63447184 |
| 21 | TAOK3 | 1.62754746 |
| 22 | INSRR | 1.52285673 |
| 23 | EPHA4 | 1.51550686 |
| 24 | SGK223 | 1.49161128 |
| 25 | SGK494 | 1.49161128 |
| 26 | WNK4 | 1.40178526 |
| 27 | MAP2K4 | 1.39905606 |
| 28 | TNK2 | 1.27890648 |
| 29 | SGK3 | 1.24455261 |
| 30 | IGF1R | 1.17350291 |
| 31 | MAP3K3 | 1.14523218 |
| 32 | PINK1 | 1.10048946 |
| 33 | ERBB2 | 1.03831135 |
| 34 | PRKAA1 | 1.01304151 |
| 35 | PRKACA | 1.00534287 |
| 36 | CAMKK2 | 0.98883462 |
| 37 | NLK | 0.98749897 |
| 38 | ADRBK2 | 0.97495712 |
| 39 | PRKCZ | 0.96438982 |
| 40 | DYRK1B | 0.95128087 |
| 41 | FER | 0.92900737 |
| 42 | PDPK1 | 0.91988924 |
| 43 | PRKG1 | 0.91311263 |
| 44 | JAK1 | 0.90598255 |
| 45 | FGFR3 | 0.87558566 |
| 46 | KDR | 0.84927090 |
| 47 | NEK9 | 0.84602321 |
| 48 | CSF1R | 0.84231644 |
| 49 | PRPF4B | 0.78508909 |
| 50 | MAPK7 | 0.74783043 |
| 51 | DAPK2 | 0.73225296 |
| 52 | FGFR2 | 0.72895923 |
| 53 | ABL2 | 0.71230806 |
| 54 | MAPKAPK3 | 0.70782898 |
| 55 | MAPK12 | 0.70498852 |
| 56 | TGFBR2 | 0.69049561 |
| 57 | MST1R | 0.68074931 |
| 58 | PKN2 | 0.66664800 |
| 59 | PDK1 | 0.66087359 |
| 60 | GRK1 | 0.66043495 |
| 61 | PRKCB | 0.62825606 |
| 62 | LATS1 | 0.62185713 |
| 63 | STK39 | 0.61902965 |
| 64 | PRKCA | 0.61775888 |
| 65 | CSNK1D | 0.60563918 |
| 66 | SGK1 | 0.60197608 |
| 67 | JAK2 | 0.59203207 |
| 68 | RPS6KA3 | 0.58093073 |
| 69 | AKT3 | 0.55927875 |
| 70 | MAPK4 | 0.54494094 |
| 71 | PRKACB | 0.52978267 |
| 72 | MAP4K2 | 0.52869958 |
| 73 | CSNK1A1 | 0.52712759 |
| 74 | STK38 | 0.52174649 |
| 75 | EPHB1 | 0.50797233 |
| 76 | STK38L | 0.48678098 |
| 77 | CDK6 | 0.47772597 |
| 78 | BLK | 0.44141658 |
| 79 | GSK3A | 0.43221621 |
| 80 | KIT | 0.42580993 |
| 81 | PRKCE | 0.41304329 |
| 82 | MYLK | 0.40827911 |
| 83 | BCR | 0.40616903 |
| 84 | TBK1 | 0.39857160 |
| 85 | MAP3K2 | 0.39832797 |
| 86 | SRC | 0.38945755 |
| 87 | CSNK1E | 0.38363103 |
| 88 | PDK2 | 0.38224773 |
| 89 | RET | 0.35376552 |
| 90 | DYRK1A | 0.34897643 |
| 91 | CAMKK1 | 0.32666931 |
| 92 | BRSK2 | 0.30530727 |
| 93 | CAMK4 | 0.30328022 |
| 94 | CSNK2A1 | 0.29030928 |
| 95 | MAP3K1 | 0.28889034 |
| 96 | TNIK | 0.28103950 |
| 97 | MAPK3 | 0.28070818 |
| 98 | CASK | 0.27626553 |
| 99 | PAK3 | 0.26791653 |
| 100 | MAP3K7 | 0.25015843 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.47339552 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.33641780 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.94819300 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.74525821 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.47742638 |
| 6 | * Retinol metabolism_Homo sapiens_hsa00830 | 3.29274092 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.21046687 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.93448813 |
| 9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.87789069 |
| 10 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.87557341 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.69488628 |
| 12 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.56724893 |
| 13 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.50695864 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.48506619 |
| 15 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.47328924 |
| 16 | * Fatty acid degradation_Homo sapiens_hsa00071 | 2.44449960 |
| 17 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.34022747 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.23304938 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 2.16308501 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.99273401 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.88716739 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.82269750 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.69936697 |
| 24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.60400474 |
| 25 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.57803191 |
| 26 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55192542 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.52181608 |
| 28 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.44333355 |
| 29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.42419681 |
| 30 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.40260394 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.34345615 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.34340078 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.31475617 |
| 34 | Prion diseases_Homo sapiens_hsa05020 | 1.30672953 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.30477927 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.21336066 |
| 37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16735063 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.10540348 |
| 39 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.05044756 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.02279601 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.01759363 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.01475704 |
| 43 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.99459447 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96386217 |
| 45 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89797771 |
| 46 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.88714420 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.88301870 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84092330 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 0.82065572 |
| 50 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.79140617 |
| 51 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.73231071 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.70174320 |
| 53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.70002800 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63836953 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.62615551 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.44919303 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.44901634 |
| 58 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.42954867 |
| 59 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.42844971 |
| 60 | Pertussis_Homo sapiens_hsa05133 | 0.31836165 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.30481360 |
| 62 | Insulin resistance_Homo sapiens_hsa04931 | 0.26166520 |
| 63 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.23563957 |
| 64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21118981 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.20214660 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.16559122 |
| 67 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.15349632 |
| 68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.10164116 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.08856671 |
| 70 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.07163691 |
| 71 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.05712086 |
| 72 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03804333 |
| 73 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.03172210 |
| 74 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.02939329 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.01869835 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.01180790 |
| 77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.01016784 |
| 78 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.00712849 |
| 79 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2776949 |
| 80 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2730878 |
| 81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.2605928 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2471854 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.2449514 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2219716 |
| 85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2120637 |
| 86 | GABAergic synapse_Homo sapiens_hsa04727 | -0.2105649 |
| 87 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1704190 |
| 88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1630225 |
| 89 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1585109 |
| 90 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1554567 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.1491084 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0967642 |
| 93 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.0830915 |
| 94 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.0805781 |
| 95 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.0800573 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0770108 |
| 97 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0671398 |
| 98 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.0608112 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | -0.0566651 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | -0.0131917 |

